title: [Cancer from the exocrine pancreas].
abstract: Improving the prognosis for patients with cancer from the exocrine pancreas (PC) represents a challenge for health-care systems in the Western world. Vague and non-specific symptoms combined with rapid deterioration of the patients' condition often make diagnosis difficult. Multimodality therapy with a combination of surgery followed by adjuvant chemotherapy has improved the long-term survival of patients. Recent data suggest improved efficacy of aggressive chemotherapy. Multidisciplinary team management and research are essential in order to further improve the outcome of patients with PC.
authors.affiliation: Onkologisk Afdeling, Odense Universitetshospital, Sdr. Boulevard 29, 5000 Odense. jon.bjerregaard@rsyd.dk
authors.forename: Jon K
authors.initials: JK
authors.lastname: Bjerregaard
authors.forename: Claus
authors.initials: C
authors.lastname: Fristrup
authors.forename: Per
authors.initials: P
authors.lastname: Pfeiffer
authors.forename: Per Michael Bau
authors.initials: PM
authors.lastname: Mortensen
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D000465:Algorithms; D006801:Humans; D010166:Palliative Care; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D012307:Risk Factors